HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Mondrian Investment Partners LTD

Key Points

• Mondrian Investment Partners LTD reduced its holdings in HCA Healthcare by 0.9%, owning 354,638 shares valued at approximately $122.5 million as of the latest SEC filing.
• HCA Healthcare reported $6.84 earnings per share for its last quarter, exceeding analyst estimates of $6.20, and reported revenue growth of 6.4% year-over-year.
• The company declared a quarterly dividend of $0.72 per share, representing an annualized yield of 0.7%, with the ex-dividend date set for September 16th.

Mondrian Investment Partners LTD reduced its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 354,638 shares of the company's stock after selling 3,367 shares during the quarter. HCA Healthcare makes up approximately 2.1% of Mondrian Investment Partners LTD's investment portfolio, making the stock its 18th biggest position. Mondrian Investment Partners LTD owned approximately 0.15% of HCA Healthcare worth $122,545,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the stock. Avantax Advisory Services Inc. increased its holdings in shares of HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock worth $2,791,000 after purchasing an additional 32 shares during the last quarter. Catalyst Financial Partners LLC increased its holdings in shares of HCA Healthcare by 4.3% in the first quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock worth $301,000 after purchasing an additional 36 shares during the last quarter. Moors & Cabot Inc. increased its holdings in shares of HCA Healthcare by 4.8% in the first quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock worth $297,000 after purchasing an additional 39 shares during the last quarter. Perigon Wealth Management LLC increased its holdings in shares of HCA Healthcare by 2.3% in the first quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock worth $621,000 after purchasing an additional 40 shares during the last quarter. Finally, Barden Capital Management Inc. grew its position in HCA Healthcare by 1.4% in the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock worth $1,009,000 after acquiring an additional 41 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on HCA. Bank of America lowered HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price target for the company. in a research report on Wednesday, July 16th. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Robert W. Baird lifted their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research report on Thursday. Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Finally, Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Nine investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $398.58.

HCA Healthcare Trading Up 0.6%

Shares of NYSE HCA traded up $2.18 during trading hours on Friday, reaching $395.83. The stock had a trading volume of 1,251,407 shares, compared to its average volume of 1,541,143. The firm has a market cap of $92.62 billion, a price-to-earnings ratio of 16.64, a P/E/G ratio of 1.24 and a beta of 1.39. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The business's fifty day moving average price is $370.53 and its two-hundred day moving average price is $351.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.50 earnings per share. Analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.